help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Niskanen, L.
Right arrow Articles by Uusitupa, M. I. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Niskanen, L.
Right arrow Articles by Uusitupa, M. I. J.
The Journal of Clinical Endocrinology & Metabolism Vol. 85, No. 6 2266-2269
Copyright © 2000 by The Endocrine Society


Original Studies

Leucine 7 to Proline 7 Polymorphism in the Neuropeptide Y Gene Is Associated with Enhanced Carotid Atherosclerosis in Elderly Patients with Type 2 Diabetes and Control Subjects1

Leo Niskanen, Matti K. Karvonen, Raisa Valve, Markku Koulu, Ullamari Pesonen, Michele Mercuri, Rainer Rauramaa, Jari Töyry, Markku Laakso and Matti I. J. Uusitupa

Departments of Clinical Nutrition (L.N., R.V., M.I.J.U.), Medicine (L.N., M.L.), and Physiology (R.R., J.T.), University of Kuopio, and Kuopio Research Institute of Exercise Medicine and Department of Clinical Physiology and Nuclear Medicine, Kuopio University Hospital (R.R., J.T.), FIN-70211 Kuopio, Finland; Department of Pharmacology and Clinical Pharmacology, University of Turku (M.K.K., M.K., U.P.), FIN-20520 Turku, Finland; and Department of Endocrinology and Metabolism, Merck Research Laboratories, Merck & Co., Inc. (M.M.), Rahway, New Jersey 07065-0900

Address all correspondence and requests for reprints to: Leo Niskanen, M.D., Department of Medicine, University of Kuopio, P.O. Box 1627, FIN-70211 Kuopio, Finland. E-mail: leo.niskanen{at}kuh.fi

We have recently demonstrated that subjects having Pro7 in the signal peptide of neuropeptide Y (NPY) have higher serum cholesterol and apolipoprotein B levels than individuals with wild-type (Leu7Leu7) signal peptide sequence. We investigated the association of Leu7Pro polymorphism with common carotid intima media thickness (IMT) assessed by ultrasonograph in patients with type 2 diabetes (n = 81; 41 men and 40 women; mean age, 67.1 yr) and nondiabetic subjects (n = 105; 48 men and 57 women; mean age, 65.5 yr) and genotyped for the Leu7Pro polymorphism in prepro-NPY. The frequency of Pro7 in prepro-NPY was 9.9% (8 of 81) in diabetic patients and 14.3% (15 of 105) in control subjects (P = 0.360). The mean common carotid IMT was 1.04 ± 0.02 mm in nondiabetic subjects without the Leu7Pro polymorphism and 1.14 ± 0.04 mm in nondiabetic subjects with in (P = 0.156) and 1.18 ± 0.03 and 1.58 ± 0.21 mm in diabetic patients without and with the Leu7Pro polymorphism (P = 0.004), respectively. In the analysis of covariance of the entire group, the mean common carotid IMT was independently associated with the Leu7Pro polymorphism (F = 5.165; P = 0.024) after adjustment for known risk factors. Thus, the presence of the Pro7 substitution in the prepro-NPY associates with increased carotid atherosclerosis.




This article has been cited by other articles:


Home page
DiabetesHome page
S. T. Ruohonen, U. Pesonen, N. Moritz, K. Kaipio, M. Roytta, M. Koulu, and E. Savontaus
Transgenic Mice Overexpressing Neuropeptide Y in Noradrenergic Neurons: A Novel Model of Increased Adiposity and Impaired Glucose Tolerance
Diabetes, June 1, 2008; 57(6): 1517 - 1525.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
J. Ma, S. Nordman, A. Mollsten, H. Falhammar, K. Brismar, G. Dahlquist, S. Efendic, and H. F Gu
Distribution of neuropeptide Y Leu7Pro polymorphism in patients with type 1 diabetes and diabetic nephropathy among Swedish and American populations
Eur. J. Endocrinol., November 1, 2007; 157(5): 641 - 645.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
D. Ribatti, M. T. Conconi, and G. G. Nussdorfer
Nonclassic Endogenous Novel Regulators of Angiogenesis
Pharmacol. Rev., June 1, 2007; 59(2): 185 - 205.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. Li, A.-C. Jonsson-Rylander, K. Abe, and Z. Zukowska
Chronic Stress Induces Rapid Occlusion of Angioplasty-Injured Rat Carotid Artery by Activating Neuropeptide Y and Its Y1 Receptors
Arterioscler. Thromb. Vasc. Biol., October 1, 2005; 25(10): 2075 - 2080.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
U. Jaakkola, T. Kuusela, T. Jartti, U. Pesonen, M. Koulu, T. Vahlberg, and J. Kallio
The Leu7Pro Polymorphism of PreproNPY Is Associated with Decreased Insulin Secretion, Delayed Ghrelin Suppression, and Increased Cardiovascular Responsiveness to Norepinephrine during Oral Glucose Tolerance Test
J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3646 - 3652.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
T. A. Manolio, E. Boerwinkle, C. J. O'Donnell, and A. F. Wilson
Genetics of Ultrasonographic Carotid Atherosclerosis
Arterioscler. Thromb. Vasc. Biol., September 1, 2004; 24(9): 1567 - 1577.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
K. Pettersson-Fernholm, M. K. Karvonen, J. Kallio, C. M. Forsblom, M. Koulu, U. Pesonen, J. A. Fagerudd, and P.-H. Groop
Leucine 7 to Proline 7 Polymorphism in the Preproneuropeptide Y Is Associated With Proteinuria, Coronary Heart Disease, and Glycemic Control in Type 1 Diabetic Patients
Diabetes Care, February 1, 2004; 27(2): 503 - 509.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. Kallio, U. Pesonen, U. Jaakkola, M. K. Karvonen, H. Helenius, and M. Koulu
Changes in Diurnal Sympathoadrenal Balance and Pituitary Hormone Secretion in Subjects with Leu7Pro Polymorphism in the Prepro-Neuropeptide Y
J. Clin. Endocrinol. Metab., July 1, 2003; 88(7): 3278 - 3283.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. Li, E. W. Lee, H. Ji, and Z. Zukowska
Neuropeptide Y-Induced Acceleration of Postangioplasty Occlusion of Rat Carotid Artery
Arterioscler. Thromb. Vasc. Biol., July 1, 2003; 23(7): 1204 - 1210.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
J. Lappalainen, H. R. Kranzler, R. Malison, L. H. Price, C. Van Dyck, R. A. Rosenheck, J. Cramer, S. Southwick, D. Charney, J. Krystal, et al.
A Functional Neuropeptide Y Leu7Pro Polymorphism Associated With Alcohol Dependence in a Large Population Sample From the United States
Arch Gen Psychiatry, September 1, 2002; 59(9): 825 - 831.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
T. Maeno, H. Koyama, H. Tahara, M. Komatsu, M. Emoto, T. Shoji, M. Inaba, T. Miki, Y. Okuno, and Y. Nishizawa
The 807T Allele in {alpha}2 Integrin Is Protective Against Atherosclerotic Arterial Wall Thickening and the Occurrence of Plaque in Patients With Type 2 Diabetes
Diabetes, May 1, 2002; 51(5): 1523 - 1528.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. Kallio, U. Pesonen, M. K. Karvonen, M. Kojima, H. Hosoda, K. Kangawa, and M. Koulu
Enhanced Exercise-Induced GH Secretion in Subjects with Pro7 Substitution in the Prepro-NPY
J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5348 - 5352.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2000 by The Endocrine Society